Intellia Therapeutics
NTLA
$6.63
Share price
-3.77%
Change (1 day)
-73.79%
Change (1 year)
EPS for Intellia Therapeutics (NTLA)
EPS in 2023 (TTM): -$5.46
According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.46. In 2022 the company made an earnings per share (EPS) of -$6.18 a decrease over its 2021 EPS that were of -$3.76.
EPS history for Intellia Therapeutics from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$5.46 | -11.65% |
| 2022 | -$6.18 | 64.36% |
| 2021 | -$3.76 | 56.67% |
| 2020 | -$2.40 | 13.21% |
| 2019 | -$2.12 | 6.53% |
| 2018 | -$1.99 | 6.99% |
| 2017 | -$1.86 | 71.4% |
| 2016 | -$1.09 | 54.62% |
| 2015 | -$0.70 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$2.18 | -60.07% | 🇺🇸 USA |